Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MOBIX LABS, INCMOBX · Entity 7651 | Director | September 14, 2026 | September 22, 2026 |
| Priveterra Acquisition Corp. IITMKR · Entity 111410 | Director | July 05, 2023 | July 13, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MOBIX LABS, INC
Report date September 14, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 98,638 |
Ending reported balance
After 2026-09-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-14 · Grant · Acquired 12,255 · Balance 79,537 F1: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on September 30, 2026. Row 2 · 2026-09-14 · Grant · Acquired 19,101 · Balance 98,638 F2: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on October 1, 2026. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.80 · Expires 2030-08-10 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 2,000 F3: These options are fully vested and exercisable. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.40 · Expires 2032-04-04 | Direct | 13,341 |
Reported balance
Holding disclosure · report date 2026-09-14 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 13,341 F3: These options are fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on September 30, 2026.
F2: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on October 1, 2026.
F3: These options are fully vested and exercisable.
Priveterra Acquisition Corp. II
Report date July 05, 2023 · Filed July 13, 2023
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 22, 2026 22:17 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 19,101 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-043759 · ownership.xml · nonDerivative · entry 2 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,638 F2 · shares: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on October 1, 2026. Read SEC document |
| September 14, 2026 Filed Sep 22, 2026 22:17 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 12,255 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-043759 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,537 F1 · shares: These Restricted Stock Units were granted to the Reporting Person on September 14, 2026 and vest on September 30, 2026. Read SEC document |
| June 30, 2026 Filed Jul 6, 2026 23:15 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 13,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-032226 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,282 F1 · shares: These Restricted Stock Units were granted to the Reporting Person on June 30, 2026 and vested on July 1, 2026. Read SEC document |
| March 30, 2026 Filed May 5, 2026 01:32 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-021203 · ownership.xml · nonDerivative · entry 2 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,622 Read SEC document |
| February 25, 2026 Filed May 5, 2026 01:32 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 14,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-021203 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,622 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on February 25, 2026 and vested on April 1, 2026. F2 · balance_after: The number of shares beneficially owned by the Reporting Person has been adjusted to account for rounding as a result of a 1-for-10 reverse stock split effected by the Issuer on April 6, 2026. Read SEC document |
| November 25, 2025 Filed Nov 29, 2025 00:50 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 39,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-025464 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,188 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on November 25, 2025 and will vest on January 1, 2026. Read SEC document |
| September 23, 2025 Filed Sep 26, 2025 00:35 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 46,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-015018 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,022 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on September 23, 2025. Read SEC document |
| September 12, 2025 Filed Sep 16, 2025 20:05 UTC | MOBIX LABS, INC MOBX · Entity 7651 | SaleClass A Common Stock | 19,953 | $0.94 | $18,791.74 |
DisclosureSEC source: 0001493152-25-013704 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,167 F1 · price: Represents the weighted average of the shares sold. The prices of the shares sold pursuant to the transactions range from $0.9418 to $0.9419 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or the security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| July 09, 2025 Filed Jul 11, 2025 20:48 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 202,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-018785 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,120 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on July 9, 2025, whereas 90% of the award was fully vested upon grant and the remaining 10% will vest on October 1, 2025. Read SEC document |
| April 10, 2025 Filed Apr 15, 2025 01:00 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-004664 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,953 F1 · shares: These Restricted Stock Units ("RSUs") were granted to the Reporting Person on April 10, 2025 and are fully vested on the grant date (April 10, 2025. Read SEC document |
| December 21, 2023 Filed Dec 27, 2023 02:48 UTC | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 73,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-129361 · tm2333669-11_4seq1.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,752 F1 · shares: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock. F1 · price: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock. Read SEC document |
| December 21, 2023 Filed Feb 28, 2025 01:06 UTC Amendment | MOBIX LABS, INC MOBX · Entity 7651 | GrantOption (Right to Buy) · Derivative | 133,416 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001493152-25-008573 · ownership.xml · derivative · entry 3 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,416 Underlying: Class A Common Stock · 133,416 shares Expires 2032-04-04 F3 · derivative.exercise_date: These options are fully vested and exercisable. F1 · balance_after: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. Read SEC document |
| December 21, 2023 Filed Feb 28, 2025 01:06 UTC Amendment | MOBIX LABS, INC MOBX · Entity 7651 | GrantOption (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001493152-25-008573 · ownership.xml · derivative · entry 2 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Class A Common Stock · 20,000 shares Expires 2030-08-10 F3 · derivative.exercise_date: These options are fully vested and exercisable. F1 · balance_after: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. Read SEC document |
| December 21, 2023 Filed Feb 28, 2025 01:06 UTC Amendment | MOBIX LABS, INC MOBX · Entity 7651 | GrantClass A Common Stock | 19,953 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-25-008573 · ownership.xml · nonDerivative · entry 1 Carpou Bill · CIK 0001985261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,953 F1 · shares: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. F2 · shares: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares and options in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock as well as options exercisable into shares of Class A Common Stock. F1 · price: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. F1 · balance_after: On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of 153,416 shares, which should have been reported as the acquisition of options and are now included in Table II. F2 · balance_after: Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these shares and options in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of shares of Class A Common Stock as well as options exercisable into shares of Class A Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.